In CKD, Ethyl pyruvate (EP), a well-established and potent HMGB1 inhibitor, selectively inhibits HMGB1 translocation from the nucleus, which inhibits its function in the cytosol and the active secretion of HMGB1 upon cell activation141. Here, HMGB1 is linked to chronic kidney disease.